Kubota Pharmaceutical Holdings
4596.TTSE GROWTHPharmaceutical
Financials · Standalone
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥36m | ¥259m | ¥214m | ¥175m | ¥173m | ¥196m |
| Operating income | −¥719m | −¥382m | −¥146m | −¥60m | −¥93m | — |
| Ordinary income | −¥741m | −¥1.3bn | −¥733m | −¥42m | −¥96m | −¥107m |
| Total assets | ¥2.1bn | ¥1.7bn | ¥2.9bn | ¥3.5bn | ¥2.0bn | ¥1.7bn |
| Net assets / equity | ¥2.0bn | ¥1.6bn | ¥2.9bn | ¥3.4bn | ¥2.0bn | ¥1.7bn |
| EPS (basic) | ¥-11.71 | ¥-23.12 | ¥-13.06 | ¥0.01 | ¥-1.18 | ¥-2.23 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 80 figures · EDINET |
| 2025-01-01 → 2025-12-31 | Annual | 195 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 78 figures · EDINET |
| 2024-01-01 → 2024-12-31 | Annual | 195 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 92 figures · EDINET |
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 78 figures · EDINET |
| 2023-01-01 → 2023-12-31 | Annual | 196 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 98 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 96 figures · EDINET |
| 2023-01-01 → 2023-03-31 | Quarterly Q1 | 77 figures · EDINET |
| 2022-01-01 → 2022-12-31 | Annual | 193 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 95 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 93 figures · EDINET |
25 more reports are still being processed.